Manhattan Scientifics - Stock

Manhattan Scientifics Debt 2024

Manhattan Scientifics Debt

-0.01 USD

Ticker

MHTX

ISIN

US5631221000

WKN

911936

In 2024, Manhattan Scientifics's total debt was -0.01 USD, a -90% change from the -0.07 USD total debt recorded in the previous year.

Manhattan Scientifics Aktienanalyse

What does Manhattan Scientifics do?

Manhattan Scientifics Inc is an innovative company that operates in the world of science and technology. The company was founded in 1994 by Marvin Maslow and is based in New York City. It primarily focuses on developing advanced technologies in the fields of materials science, biotechnology, and medical technology. The business model of Manhattan Scientifics Inc is based on the discovery and development of new technologies, which are then licensed or sold. The company specializes in technology development and works closely with scientific institutions and researchers around the world. In the past, the company has collaborated closely with NASA and the Los Alamos National Laboratory, and has been able to bring several successful products to market. The various divisions of Manhattan Scientifics Inc include nanotechnology, biotechnology, and medical technology. In the field of nanotechnology, the company has developed advanced technologies for the production of ultralight, highly strong materials. These materials are used in aerospace, construction, and other industries where lightweight and durable materials are needed. The biotechnology division of Manhattan Scientifics Inc focuses on the development of novel therapies for cancer and other diseases. The company has successfully developed a new cancer therapy based on magnetic nanoparticles. These nanoparticles are introduced into the body and attach to cancer cells. They are then attracted and killed by an external magnetic field. Medical technology is another important division of Manhattan Scientifics Inc. The company has developed advanced technologies for the production of medical devices that provide more precise surgeries and treatments. One of Manhattan Scientifics Inc's successful innovations is a device that can precisely target tumors with high-energy radiation to destroy them. Manhattan Scientifics Inc has brought several successful products to market in the past. One example of such a product is the Greenshift Corporation System, which helps reduce emissions from airplanes. The company has also had successful collaborations with NASA on various projects, including the development of super-lightweight carbon fiber components. Overall, Manhattan Scientifics Inc is an innovative company that specializes in the development of new technologies. The company has successfully worked in various fields, including nanotechnology, biotechnology, and medical technology. Its business model is based on the discovery and development of new technologies, which are then licensed or sold. Through its collaborations with scientific institutions and researchers around the world, the company has developed and brought several successful products to market. Manhattan Scientifics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Manhattan Scientifics's Debt Structure

Manhattan Scientifics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Manhattan Scientifics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Manhattan Scientifics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Manhattan Scientifics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Manhattan Scientifics Stock

What is the debt of Manhattan Scientifics this year?

Manhattan Scientifics has a debt level of -0.01 USD this year.

What was the debt of Manhattan Scientifics compared to the previous year?

The debt of Manhattan Scientifics has increased by -90% compared to the previous year dropped.

What are the consequences of high debt for investors in Manhattan Scientifics?

High debt can pose a risk for investors of Manhattan Scientifics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Manhattan Scientifics?

Low debt means that Manhattan Scientifics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Manhattan Scientifics affect the company?

An increase in debt of Manhattan Scientifics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Manhattan Scientifics affect the company?

A reduction in debt of Manhattan Scientifics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Manhattan Scientifics?

Some factors that can influence the debt of Manhattan Scientifics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Manhattan Scientifics so important for investors?

The debts of Manhattan Scientifics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Manhattan Scientifics take to change the debt?

To change the debt, Manhattan Scientifics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Manhattan Scientifics pay?

Over the past 12 months, Manhattan Scientifics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Manhattan Scientifics is expected to pay a dividend of 0 USD.

What is the dividend yield of Manhattan Scientifics?

The current dividend yield of Manhattan Scientifics is .

When does Manhattan Scientifics pay dividends?

Manhattan Scientifics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Manhattan Scientifics?

Manhattan Scientifics paid dividends every year for the past 0 years.

What is the dividend of Manhattan Scientifics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Manhattan Scientifics located?

Manhattan Scientifics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Manhattan Scientifics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Manhattan Scientifics from 6/11/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/11/2024.

When did Manhattan Scientifics pay the last dividend?

The last dividend was paid out on 6/11/2024.

What was the dividend of Manhattan Scientifics in the year 2023?

In the year 2023, Manhattan Scientifics distributed 0 USD as dividends.

In which currency does Manhattan Scientifics pay out the dividend?

The dividends of Manhattan Scientifics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Manhattan Scientifics

Our stock analysis for Manhattan Scientifics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Manhattan Scientifics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.